Sayuri Hirano

Title: Sayuri Hirano: Innovator in Asymmetric Synthesis

Introduction

Sayuri Hirano is a prominent inventor based in Osaka, Japan. She has made significant contributions to the field of asymmetric synthesis, holding a total of 5 patents. Her work focuses on developing efficient methods for producing optically active compounds, which are crucial in various pharmaceutical applications.

Latest Patents

Hirano's latest patents include a method for producing optically active 1,4-benzothiazepine-1-oxide derivative. This invention addresses the challenge of providing an efficient asymmetric synthesis method for this specific compound. The process involves reacting a 1,4-benzothiazepine derivative or its salt with a titanium compound, a chiral diol compound, water, and an oxidant in a solvent. Another notable patent is a method for producing an optically active pyrimidinamide derivative on an industrial scale. This method includes an asymmetric reduction reaction followed by a deprotection reaction, ultimately leading to the desired compound.

Career Highlights

Throughout her career, Sayuri Hirano has worked with esteemed organizations such as Takeda Pharmaceutical Company Limited and Dot Therapeutics, Inc. Her experience in these companies has allowed her to refine her skills and contribute to groundbreaking research in the pharmaceutical industry.

Collaborations

Hirano has collaborated with notable colleagues, including Masatoshi Yamada and Yoshiyuki Takeda. These partnerships have further enhanced her research and development efforts in the field of asymmetric synthesis.

Conclusion

Sayuri Hirano is a trailblazer in the realm of asymmetric synthesis, with a focus on producing optically active compounds. Her innovative methods and collaborations have made a significant impact in the pharmaceutical industry.